The first stop for professional medicines advice

Orlistat

Published
Topics: Mental health and illnessNutritional and metabolic disordersOrlistat · Patent expiriesSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Medicine Compliance Aid Stability
    1. Xenical · Neon Healthcare
    2. generic · Mylan
  3. Lactation Safety Information

dm+d

116093009

Medicine Compliance Aid Stability

XenicalNeon Healthcare

Neon Healthcare
Xenical
Capsules 120mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from moisture - contains a desiccant if packaged as a bottle. Max 7 days in MCA.
22 November 2022
Usage of Medicines in Compliance Aids

genericMylan

Mylan
generic
Capsules 60mg, 120mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Contains desiccant.
2 December 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Yes
-
No published evidence of safety
Negligible levels anticipated in milk due to the drug’s properties and minimal maternal absorption
The use of vitamin supplements should be considered if there is concern about maternal deficiency of fat soluble vitamins
7 August 2020
Bibliography